Therapy News and Research

RSS

Listening to yoga music before sleep has beneficial impact on heart rate variability

Listening to yoga music at bedtime is good for the heart, according to research presented today at ESC Congress 2018.

27 Aug 2018

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.

27 Aug 2018

Death of Sen. John McCain sheds new light on aggressive brain tumor

The death today of Sen. John McCain (R-Ariz.) sheds a new light on glioblastoma, a form of brain cancer that the American Brain Tumor Association estimated would be diagnosed in nearly 13,000 people this year.

27 Aug 2018

Researchers investigate ability of Masimo Ori to show oxygenation trends during moderate hyperoxia

Masimo announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the Netherlands, and Ghent University, Belgium, investigated the ability of Masimo ORi to show trends in oxygenation in the moderate hyperoxic region.

27 Aug 2018

Oxygen therapy does not prevent development of heart failure in patients with heart attack

Oxygen therapy does not prevent the development of heart failure. Neither does it reduce the long-term risk of dying for patients with suspected heart attack.

27 Aug 2018

Impaired mental status linked to doubled risk of death after heart attack in elderly patients

Impaired mental status is associated with a doubled risk of death one year after a heart attack in elderly patients, according to research presented today at ESC Congress 2018.

27 Aug 2018

$Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction$

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Data from the TRANSITION study presented today at the European Society of Cardiology Congress in Munich, Germany has shown that Entresto® can be initiated early and safely in a wide range of heart failure patients with reduced ejection fraction who have been stabilized after hospitalization due to an acute heart failure episode.

25 Aug 2018

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Forbius announced today that it has been awarded a Product Development grant totaling $18.75 million from the Cancer Prevention and Research Institute of Texas.

25 Aug 2018

Patients with blood pressure must start treatment with two drugs as a single pill

A single pill with two drugs could transform blood pressure treatment, according to the 2018 European Society of Cardiology and European Society of Hypertension Guidelines on arterial hypertension published online today in European Heart Journal, and on the ESC website.

25 Aug 2018

Pregnant women with heart disease must give birth at 40 weeks gestation

Pregnant women with heart disease should give birth at no later than 40 weeks gestation. That is one of the recommendations in the 2018 European Society of Cardiology Guidelines for the management of cardiovascular diseases during pregnancy published online today in European Heart Journal, and on the ESC website.

25 Aug 2018

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma.

25 Aug 2018

Researchers develop new system for effective cancer diagnosis and treatment

A research group consisting of scientists from NUST MISIS, the Technical University of Munich, Helmholtz Zentrum München, the University of Duisburg-Essen, and the University of Oldenburg has developed a system that allows doctors to both improve the accuracy of diagnosing malignant cells and to provide additional opportunities for cancer treatment.

24 Aug 2018

Alternative method identified for delivering nusinersen to spinal muscular atrophy patients

A new report has identified an alternative method to deliver nusinersen to patients with spinal muscular atrophy using a subcutaneous intrathecal catheter system configured by connecting an intrathecal catheter to an implantable infusion port.

24 Aug 2018

Proteins that protect neurons from destruction can be delivered through nose

Protective proteins that mitigate the destruction of nerve cells after a stroke can be administered into the brain through the nose, as Heidelberg University researchers demonstrated using a mouse model.

24 Aug 2018

HU researchers develop new biological drug that may cure acute myeloid leukemia

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefited from new treatments, there has been no encouraging news for most leukemia patients for the past 40 years. Until now.

24 Aug 2018

Researchers find new therapy to prevent drug resistance for melanoma patients

Mount Sinai researchers have discovered a previously unknown reason for drug resistance in a common subtype of melanoma, one of the deadliest forms of cancer, and in turn, have found a new therapy that could prevent or reverse drug resistance for melanoma patients with a particular gene mutation, according to a study published in Nature Communications in August.

24 Aug 2018

Researchers take major step in eliminating cancer without harming healthy tissue

A major advance towards targeting cancer without harming healthy tissue has been discovered by University of Bristol researchers.

24 Aug 2018

New treatment destroys part of tumor and attacks persistent surviving cancer cells

Scientists at the VIB-UGent Center for Medical Biotechnology have taken important steps forward in the development of a cancer-targeting immunotherapy.

24 Aug 2018

FDA grants Breakthrough designation to Dthera Sciences' development-stage product for Alzheimer's

Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.

24 Aug 2018

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

The Muscular Dystrophy Association today announced the award of 34 new grants totaling more than $9.9 million for its summer round of funding. These new grants represent a continued commitment by MDA to fund groundbreaking research that will accelerate treatments and cures for the more than 40 diseases in its program.

24 Aug 2018

Therapy News and Research

Listening to yoga music before sleep has beneficial impact on heart rate variability

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Death of Sen. John McCain sheds new light on aggressive brain tumor

Researchers investigate ability of Masimo Ori to show oxygenation trends during moderate hyperoxia

Oxygen therapy does not prevent development of heart failure in patients with heart attack

Impaired mental status linked to doubled risk of death after heart attack in elderly patients

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Patients with blood pressure must start treatment with two drugs as a single pill

Pregnant women with heart disease must give birth at 40 weeks gestation

Inhibition of miR-24-3p may serve as potential treatment target for mesothelioma

Researchers develop new system for effective cancer diagnosis and treatment

Alternative method identified for delivering nusinersen to spinal muscular atrophy patients

Proteins that protect neurons from destruction can be delivered through nose

HU researchers develop new biological drug that may cure acute myeloid leukemia

Researchers find new therapy to prevent drug resistance for melanoma patients

Researchers take major step in eliminating cancer without harming healthy tissue

New treatment destroys part of tumor and attacks persistent surviving cancer cells

FDA grants Breakthrough designation to Dthera Sciences' development-stage product for Alzheimer's

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News